Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[PET-patterns of cognitive impairment in patients with multiple sclerosis.]
Anti-neurofascin antibody in patients with combined central and peripheral demyelination.
Predictors of effectiveness of multidisciplinary rehabilitation treatment on motor dysfunction in multiple sclerosis.
Feasibility of Cell Therapy in Multiple Sclerosis: A Systematic Review of 83 Studies.
Ophthalmic manifestations of systemic diseases-part 2: metabolic, infections, granulomatoses, demyelination, and skeletal dysplasias.
How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.
Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T.
Cerebrospinal fluid derived immunoglobulin G of different multiple sclerosis patients share mutated sequences in complementarity determining regions.
Silent, invisible and unacknowledged: experiences of young caregivers of single parents diagnosed with multiple sclerosis.
Targeting the low-hanging fruit of neurodegeneration.
Seminal vesicle fluid ameliorates experimental autoimmune encephalomyelitis by increasing FoxP3(+) regulatory T-cell numbers.
Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0) - Development of an Outcome Instrument for Educational Interventions.
Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran.
Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
The Inflammasome Pyrin Contributes to Pertussis Toxin-Induced IL-1β Synthesis, Neutrophil Intravascular Crawling and Autoimmune Encephalomyelitis.
Severe Cognitive Impairment Associated With Intrathecal Antibodies to the NR1 Subunit of the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis.
Difference in Motor Fatigue between Patients with Stroke and Patients with Multiple Sclerosis: A Pilot Study.
Novartis provides update on fingolimod Phase III trial in primary progressive MS (PPMS)
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?
Vitamin D, steroid hormones, and autoimmunity.
Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous.
Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes.
Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors in T cell subsets.
Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.
Developmentally regulated GTP-binding protein 2 ameliorates EAE by suppressing the development of TH17 cells.
Pages
« first
‹ previous
…
494
495
496
497
498
499
500
501
502
…
next ›
last »